These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28364937)

  • 1. National logistics working groups: A landscape analysis study.
    Leab D; Schreiber B; Kasonde M; Bessat O; Bui S; Loisel C
    Vaccine; 2017 Apr; 35(17):2233-2242. PubMed ID: 28364937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the policy environment for immunization supply chains: Lessons learned from landscape analyses in Uganda and Senegal.
    Luzze H; Badiane O; Mamadou Ndiaye EH; Ndiaye AS; Atuhaire B; Atuhebwe P; Guinot P; Fry Sosne E; Gueye A
    Vaccine; 2017 Apr; 35(17):2141-2147. PubMed ID: 28364922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The people factor: An analysis of the human resources landscape for immunization supply chain management.
    Kasonde M; Steele P
    Vaccine; 2017 Apr; 35(17):2134-2140. PubMed ID: 28364921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming cold chain performance and management in lower-income countries.
    Brison M; LeTallec Y
    Vaccine; 2017 Apr; 35(17):2107-2109. PubMed ID: 28364916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The imperative for stronger vaccine supply and logistics systems.
    Zaffran M; Vandelaer J; Kristensen D; Melgaard B; Yadav P; Antwi-Agyei KO; Lasher H
    Vaccine; 2013 Apr; 31 Suppl 2():B73-80. PubMed ID: 23598495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the establishment and strengthening of national immunization technical advisory groups: analysis from the 2013 WHO/UNICEF joint reporting form, data for 2012.
    Duclos P; Dumolard L; Abeysinghe N; Adjagba A; Janusz CB; Mihigo R; Mosina L; Takashima Y; Oztürk MH
    Vaccine; 2013 Nov; 31(46):5314-20. PubMed ID: 24055304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunisation program reviews in East and Southern Africa: 2012-2018; key lessons.
    Shibeshi ME; Masresha BG; Daniel F
    Pan Afr Med J; 2020; 37():385. PubMed ID: 33796198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of New Vaccine Introduction - Worldwide, September 2016.
    Loharikar A; Dumolard L; Chu S; Hyde T; Goodman T; Mantel C
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(41):1136-1140. PubMed ID: 27764083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
    Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
    Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costing analysis and anthropological assessment of the vaccine supply chain system redesign in the Comé District (Benin).
    Huang XX; Guillermet E; Le Gargasson JB; Alfa DA; Gbodja R; Sossou AJ; Jaillard P
    Vaccine; 2017 Apr; 35(17):2183-2188. PubMed ID: 28364928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The landscape of vaccines in China: history, classification, supply, and price.
    Zheng Y; Rodewald L; Yang J; Qin Y; Pang M; Feng L; Yu H
    BMC Infect Dis; 2018 Oct; 18(1):502. PubMed ID: 30286735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What vaccine product attributes do immunization program stakeholders value? Results from interviews in six low- and middle-income countries.
    Kristensen DD; Bartholomew K; Villadiego S; Lorenson K
    Vaccine; 2016 Dec; 34(50):6236-6242. PubMed ID: 27836438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Advisory Group: conclusions and recommendations.
    Pan American Health Organization PAHO. Expanded Program on Immunization EPI. Global Advisory Group
    EPI Newsl; 1986 Feb; 13(1):4-6. PubMed ID: 12314333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latin American countries set 1985 EPI targets at Lima meeting.
    EPI Newsl; 1984 Apr; 6(2):1-3. PubMed ID: 12313077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report on: "The 1st Workshop on National Immunization Programs and Vaccine Coverage in ASEAN Countries, April 30, 2015, Pattaya, Thailand".
    Hattasingh W; Pengsaa K; Thisyakorn U;
    Vaccine; 2016 Mar; 34(10):1233-40. PubMed ID: 26805596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective vaccine management and Oman's healthcare system's challenge to maintain high global standards.
    Al-Abri SS; Al-Rawahi B; Abdelhady D; Al-Abaidani I
    J Infect Public Health; 2018; 11(5):742-744. PubMed ID: 29779847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A network to "eradicate" poor-quality vaccines.
    Vaccine Immun News; 1998 Mar; (6):1-3. PubMed ID: 12179909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outsourcing vaccine logistics to the private sector: The evidence and lessons learned from the Western Cape Province in South-Africa.
    Lydon P; Raubenheimer T; Arnot-Krüger M; Zaffran M
    Vaccine; 2015 Jun; 33(29):3429-34. PubMed ID: 25819709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global routine vaccination coverage, 2011.
    Centers for Disease Control and Prevention
    MMWR Morb Mortal Wkly Rep; 2012 Nov; 61(43):883-5. PubMed ID: 23114256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.